Tailor-made therapy of multi-resistant tuberculosis

The successful treatment of multidrug-resistant tuberculosis requires clarification in advance as to which antibiotics the pathogens are resistant to. Classic testing in the laboratory is very time-consuming and delays the start of therapy. Researchers from the Research Center Borstel, the Leibniz Lung Center, and the German Center for Infection Research (DZIF) have now prepared a catalogue of all mutations in the genome of tuberculosis bacteria and on the basis of a genomesequencing can quickly and cheaply predict which medicines are most effective for tuberculosis treatment. Read here.
10 views0 comments

Recent Posts

See All

WHO 2021 Genetic Susceptibility Testing Statement

This document summarizes the WHO’s review of various diagnostics for TB. Most of it is not new, but important additions are evaluation of molecular methods for detection of resistance to INH (pages 50